Literature DB >> 26659216

Suboptimal Trichomonas vaginalis Antigen Test Performance in a Low-Prevalence Sexually Transmitted Infection Community.

Kimber L Munson1, Maureen Napierala1, Erik Munson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26659216      PMCID： PMC4733211          DOI： 10.1128/JCM.02949-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  12 in total

Review 1.  Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel.

Authors:  W Cates
Journal:  Sex Transm Dis       Date:  1999-04       Impact factor: 2.830

2.  Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions.

Authors:  Erik Munson; Maureen Napierala; Janice Basile; Cheryl Miller; Jason Burtch; Jeanne E Hryciuk; Ronald F Schell
Journal:  Diagn Microbiol Infect Dis       Date:  2010-09       Impact factor: 2.803

3.  Persistent, undetected Trichomonas vaginalis infections?

Authors:  Thomas A Peterman; Lin H Tian; Carol A Metcalf; C Kevin Malotte; Sindy M Paul; John M Douglas
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079

4.  Observation of probable persistent, undetected Trichomonas vaginalis infection among HIV-positive women.

Authors:  Megan Gatski; Patricia Kissinger
Journal:  Clin Infect Dis       Date:  2010-07-01       Impact factor: 9.079

5.  Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens.

Authors:  Jill S Huppert; Byron E Batteiger; Phillip Braslins; James A Feldman; Marcia M Hobbs; Heather Z Sankey; Arlene C Sena; Karen A Wendel
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

6.  Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women.

Authors:  Jill S Huppert; Joel E Mortensen; Jennifer L Reed; Jessica A Kahn; Kimberly D Rich; William C Miller; Marcia M Hobbs
Journal:  Clin Infect Dis       Date:  2007-06-06       Impact factor: 9.079

7.  Performance of a new, rapid assay for detection of Trichomonas vaginalis.

Authors:  Ann Kurth; William L H Whittington; Matthew R Golden; Katherine K Thomas; King K Holmes; Jane R Schwebke
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection.

Authors:  L Campbell; V Woods; T Lloyd; S Elsayed; D L Church
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

9.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Authors:  Madeline Sutton; Maya Sternberg; Emilia H Koumans; Geraldine McQuillan; Stuart Berman; Lauri Markowitz
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

10.  Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence.

Authors:  Erik Munson; Maureen Napierala; Robin Olson; Tina Endes; Timothy Block; Jeanne E Hryciuk; Ronald F Schell
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.